D. E. Shaw & Co., Inc. Genetron Holdings LTD Transaction History

D. E. Shaw & Co., Inc.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$0.91 - $1.69 $68,030 - $126,342	-74,759 Reduced 71.23%	30,190 $24,000
Q2 2022 Aug 15, 2022	SELL	$1.28 - $2.4 $63,930 - $119,870	-49,946 Reduced 32.25%	104,949 $178,000
Q1 2022 May 16, 2022	SELL	$2.19 - $6.09 $48,453 - $134,741	-22,125 Reduced 12.5%	154,895 $339,000
Q4 2021 Feb 14, 2022	BUY	$5.81 - $14.39 $48,083 - $119,091	8,276 Added 4.9%	177,020 $1.08 Million
Q3 2021 Nov 15, 2021	BUY	$11.55 - $20.3 $210,129 - $369,317	18,193 Added 12.08%	168,744 $2.34 Million
Q2 2021 Aug 16, 2021	BUY	$17.9 - $23.29 $194,358 - $252,882	10,858 Added 7.77%	150,551 $3.03 Million
Q1 2021 May 17, 2021	BUY	$13.71 - $30.64 $251,482 - $562,029	18,343 Added 15.12%	139,693 $3 Million
Q4 2020 Feb 16, 2021	BUY	$9.31 - $14.0 $1.13 Million - $1.7 Million	121,350 New	121,350 $1.7 Million

7.5K

Ticker GTH
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 90,602,304
Description
Genetron Holdings Limited, a precision oncology company, engages in the cancer molecular profiling, and harnessing technologies in molecular biology and data science for cancer treatment. The company offers diagnosis and monitoring services, and early screening services through laboratory developed tests services. It also provides in-vitro diagn...

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.